From: Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
Radiation technique | Number of patients treated n(%) | |
---|---|---|
3D-CRT | 50 (76%) | |
IMRT | 16 (24%) | |
Radiation dose planned n(%) | Number of patients with dose reduction | |
10-15 Gy | 0 (0%) | 0 |
15-20 Gy | 0 (0%) | 0 |
20-25 Gy | 0 (0%) | 0 |
25-30 Gy | 3 (5%) | 0 |
30-35 Gy | 1 (2%) | 0 |
35-40 Gy | 0 (0%) | 0 |
40-45 Gy | 1 (2%) | 0 |
45-50 Gy | 6 (9%) | 0 |
50-55 Gy | 45 (70%) | 0 |
55-60 Gy | 9 (14%) | 1 (Reduced to 12 Gy) |
60-65 Gy | 1 (2%) | 0 |
Median: 51.9 Gy | ||
Range: 25.0-63 Gy | Total: 1 (out of 66) (2%) |